$Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.(600196)$
Established in 1994, Shanghai Fosun Pharma is an integrated healthcare group in China offering pharmaceutical products, medical devices, and healthcare services via its hospital network, and the healthcare arm of Fosun Group. Its vision is to become a first-tier enterprise in the global mainstream pharmaceutical and healthcare market. Fosun’s pharmaceutical portfolio contributed ~74% of 2021 revenue, while other key contributing segments were medical devices and healthcare services. In terms of geography, ~65% of its FY21 revenue was derived from China. While Fosun provides medium-term exposure to China’s growing demand for healthcare driven by increasing disposable income and aging population trends, near-term factors which may influence share price performance include market worries over its parent’s liquidity, expectations for pricing pressure from ongoing healthcare sector reforms and higher expenses relating to its research and development (R&D), and growth plans. The company ESG rating pegs it at the median of global peers.
I would not be buying this stock at the moment given the market weakness and the issues in China. Will actually sell it if I am holding it.
DYODD
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- JasonAngsh·2022-09-16👍1Report
- Yeohaingee·2022-09-16Ok1Report
- Rcsl·2022-09-16👍1Report
- WR38·2022-09-16okie1Report
- NG1970·2022-09-16like like like1Report